SpringWorks CareConnections® for HCPs

SpringWorks CareConnections provides personalized support services and resources to help your patients get started and stay on track with GOMEKLI® (mirdametinib).

Begin Enrollment

Financial Assistance & Insurance Navigation

We’ll help navigate coverage and connect your patients to financial assistance options that may be available.

Your eligible patients with commercial insurance may pay as little as a $0 copay per 21-day supply of GOMEKLI.*

SpringWorks CareConnections may also help with eligible out-of-pocket costs incurred by your patients for certain treatment-related tests, examinations, and/or specialty visits during treatment with GOMEKLI.*

Learn More

Ordering Information

GOMEKLI is available through a limited Specialty Pharmacy network or for eligible medically integrated dispensing (MID) pharmacies by ordering directly through one of our Specialty Distributor partners.

Learn More

Resources & Forms

Downloadable resources and tools for you and your office staff to further support your patients.

Learn More

Patients enrolled in patient support programs are more likely to stay on treatment1

Have Questions?

Call SpringWorks
CareConnections today

844-CARES-55

(844-227-3755)

Monday-Friday
8 AM-8 PM ET

Field Access
Manager (FAM) Support

For questions about patient access to
GOMEKLI, click to connect with a FAM

Arrow

*Terms and conditions apply. Copay program for GOMEKLI and reimbursement for eligible treatment-related costs are subject to annual benefit maximums. To receive the reimbursement of eligible treatment-related expenses, an Explanation of Benefits (EOB) form must be submitted, along with copies of receipts for any payments made. Full terms and conditions provided during enrollment process and are available upon request by contacting SpringWorks CareConnections at 844-CARES-55 (844-227-3755).

Reference: 1. Zuckerman AD, Renfro CP, Bryan D, et al. Putting patients first: Frontline insights on designing and administering manufacturer patient financial support programs. Am J Health Syst Pharm. 2026;83(9):e363-e369.

© 2026 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved.

OGSIVEO, GOMEKLI, PIMJETMI, and SpringWorks CareConnections are registered trademarks of Merck KGaA, Darmstadt, Germany and/or its affiliates. All other trademarks are the property of their respective owners.

EMD Serono, Inc. and SpringWorks Therapeutics, Inc. are healthcare companies of Merck KGaA, Darmstadt, Germany.

US-GOM-01397  11/26

This site is intended for U.S. audiences only.

This site is intended for U.S. audiences only.

Cookie Settings